Skip to main content

ASCO: Survivors of Early Breast Cancer Can Successfully Attempt Pregnancy

Medically reviewed by Carmen Pope, BPharm. Last updated on May 24, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, May 23, 2024 -- Most survivors of stage 0 to III breast cancer who attempt pregnancy postdiagnosis are able to become pregnant and have a live birth, according to a study presented at the annual meeting of the American Society of Clinical Oncology, held from May 31 to June 4 in Chicago.

Kimia Sorouri, M.D., M.P.H., from the Dana-Farber Cancer Institute in Boston, and colleagues conducted a prospective cohort study involving women with stage 0 to III breast cancer diagnosed at age 40 years or younger from 2006 to 2016 who reported attempting pregnancy postdiagnosis.

The researchers found that 16 percent of the 1,213 eligible participants reported any attempt of pregnancy during a median follow-up of 11 years. Seventy-three percent of those attempting pregnancy reported one or more pregnancies after diagnosis and 65 percent reported one or more live births. From diagnosis to first pregnancy, there was a median of 48 months. Older age at diagnosis was negatively associated with pregnancy in the multivariable model (odds ratio, 0.82 per-year increase), while financial comfort at baseline was positively associated with pregnancy (odds ratio, 2.04). Older age at diagnosis was also negatively associated with live births (odds ratio, 0.82 per-year increase), while a positive association was seen for having undergone fertility preservation at diagnosis (odds ratio, 2.78).

"All young patients interested in fertility preservation should have equitable access to preserve future fertility options," Elizabeth Comen, M.D., from the Memorial Sloan Kettering Cancer Center in New York City, said in a statement.

Several authors disclosed ties to the pharmaceutical, medical device, and medical technology industries.

Press Release

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

NCCN: Cancer Drug Shortages Remain a Challenge for Clinicians

FRIDAY, June 28, 2024 -- Almost 90 percent of medical centers report cancer drug shortages, which often impact clinical trials, according to the results of a National...

Acupuncture Reduces Endocrine Symptoms, Hot Flashes in Breast Cancer

MONDAY, June 24, 2024 -- A 10-week acupuncture intervention significant reduces endocrine symptoms and hot flashes among women with breast cancer receiving endocrine therapy (ET)...

Study Quantifies Risk for Gastric, Breast Cancer for Germline CDH1 P/LP Variants

FRIDAY, June 21, 2024 -- The cumulative risk for advanced gastric cancer varies from 6.5 to 10.3 percent for carriers of germline CDH1 pathogenic/likely pathogenic (P/LP)...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.